EDAP TMS S.A. (EDAP)
NASDAQ: EDAP · Real-Time Price · USD
2.340
-0.060 (-2.50%)
Sep 18, 2025, 4:00 PM EDT - Market closed
EDAP TMS Revenue
EDAP TMS had revenue of 16.04M EUR in the quarter ending June 30, 2025, with 1.60% growth. This brings the company's revenue in the last twelve months to 63.02M, up 1.56% year-over-year. In the year 2024, EDAP TMS had annual revenue of 64.12M with 6.11% growth.
Revenue (ttm)
63.02M EUR
Revenue Growth
+1.56%
P/S Ratio
1.21
Revenue / Employee
203,284 EUR
Employees
310
Market Cap
87.50M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 64.12M | 3.69M | 6.11% |
| Dec 31, 2023 | 60.42M | 5.31M | 9.64% |
| Dec 31, 2022 | 55.11M | 11.04M | 25.06% |
| Dec 31, 2021 | 44.07M | 2.40M | 5.77% |
| Dec 31, 2020 | 41.66M | -3.25M | -7.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
EDAP News
- 2 days ago - Focal One® HIFU Receives Prestigious Innovation Award - GlobeNewsWire
- 10 days ago - EDAP Receives HIFU Reimbursement for Prostate Cancer in France - GlobeNewsWire
- 21 days ago - EDAP TMS S.A. (EDAP) Q2 2025 Earnings Conference Call Transcript - Seeking Alpha
- 21 days ago - EDAP Reports Strong Second Quarter 2025 HIFU Results - GlobeNewsWire
- 23 days ago - EDAP Announces Letter of Intent for 36 Million Euro Credit Facility to Accelerate Growth and Strategic Expansion - GlobeNewsWire
- 24 days ago - EDAP to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 6 weeks ago - EDAP to Announce Second Quarter 2025 Financial Results on August 28, 2025 - GlobeNewsWire
- 2 months ago - EDAP Announces Transition from Foreign Private Issuer to U.S. Domestic Filer Status - GlobeNewsWire